干细胞和器官:临床前模型的范式转变,走向个性化医疗
Eleanor Luce1, Jean-Charles Duclos-Vallee1
1Unité Mixte de Recherche (UMR_S) 1193, INSERM/Université Paris-Saclay, F-94800 Villejuif, France.
Pharmaceuticals (Basel, Switzerland)
|July 30, 2025
概括
人类多能干细胞 (hPSC) 和有机体提供了更具预测性的临床前药物开发模型. 这些与人类相关的系统改善了个性化医疗,减少了动物试验,推动了制药研究.
科学领域:
- 生物医学研究生物医学研究
- 药物开发 药物开发
- 干细胞生物学 干细胞生物学
背景情况:
- 人类多能干细胞 (hPSC) 和有机体为制药研究提供了先进的模型.
- 这些系统比传统方法更好地模仿人类生理学,遗传变异和疾病途径.
研究的目的:
- 审查hPSC和有机技术如何提高临床前药物开发的预测能力.
- 评估它们在精准医学中的作用,并解决伦理方面的考虑.
主要方法:
- 在药物发现中对hPSC和有机体系统进行全面的文献综述.
- 专注于患者衍生模型,omics集成,生物工程和药物查中的AI.
主要成果:
- 在复制人类疾病方面,hPSC和有机体平台超过了二维培养和动物模型.
- 这些模型使个性化药物测试成为可能,改善了疗效和安全性预测.
- 通过减少动物使用,以符合3Rs (替代,减少,改进) 的道德准则.
结论:
- 干细胞和有机体系统提供与人类相关的,道德的和个性化的生物医学研究方法.
- 标准化,可扩展性和可重复性挑战正在通过自动化和多omics来解决.
- 跨学科的创新将加快采用,桥梁临床前和临床药物开发通过合作.
相关概念视频
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K


